EUVIMEDSkopri EUVIMED
Crossref

Dual Assay Validation of Rosmarinus officinalis Extract as an Inhibitor of SARS‐CoV‐2 Spike Protein: Combining Pseudovirus Testing, Yeast Two‐Hybrid, and UPLC‐Q Exactive Orbitrap‐MS Profiling

Yujing Huang iD, Rufeng Luo, Chenjing Tian, Duntao Zu, Jianni Yang, Wenlin Chen, Dingqiang Huang, Siyan Duan, Shunxin Yan, Yujia Yuan, Shengrong Li, Haibo Zhou iD and 3 more

Phytochemical Analysis · 2025

DOI: 10.1002/pca.3467 ↗

At a glance

Journal article in Phytochemical Analysis, 2025. Written by Yujing Huang and 14 co-authors. Institution: School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, China. Major MEDLINE topics: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Antiviral Agents, Plant Extracts. Cited 1 times so far (Crossref); 43 references. Funded by: Guangzhou Basic and Applied Basic Research Foundation - Science and Technology Elite "Piloting" Project, National Natural Science Foundation of China, GuangDong Basic and Applied Basic Research Foundation Natural Science Foundation Project.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Introduction

This study evaluates the effectiveness of Traditional Chinese Medicine (TCM) extracts in blocking the interaction between the SARS‐CoV‐2 Spike protein and human ACE2 receptor, utilizing a dual‐method approach to explore the antiviral potential of natural compounds.

Objectives

This work aims to evaluate the capability of TCM extracts in inhibiting the SARS‐CoV‐2 Spike protein and ACE2 receptor interaction using advanced biochemical assays.

Methods

A dual‐method screening approach was utilized, beginning with a pseudovirus assay to assess the inhibition capabilities of TCM extracts in vitro, followed by a split‐ubiquitin yeast two‐hybrid (Y2H) system to validate interactions in live cells. Active compounds were characterized and quantified using UPLC‐Q‐Exactive‐Orbitrap‐MS.

Results

Among the 91 TCM extracts tested, Rosmarinus officinalis exhibited the most potent inhibition in both pseudovirus and Y2H assays, significantly reducing viral entry and disrupting the Spike–ACE2 interaction. Comprehensive chemical profiling via UPLC‐Q‐Exactive‐Orbitrap‐MS identified 132 compounds, including phenolics, flavonoids, and terpenoids.

Conclusion

This research validates the use of TCM extracts in viral inhibition strategies, demonstrating the utility of integrating traditional remedies with modern scientific approaches to discover new therapeutic agents.

Subjects

MeSH terms (MEDLINE)

Spike Glycoprotein, CoronavirusSARS-CoV-2Antiviral AgentsPlant ExtractsRosmarinusHumansAngiotensin-Converting Enzyme 2Two-Hybrid System TechniquesChromatography, High Pressure LiquidMass SpectrometryCOVID-19 Drug TreatmentVirus InternalizationDrugs, Chinese Herbal

Author keywords

Rosmarinus officinalisSARS‐CoV‐2Traditional Chinese Medicine (TCM)high‐throughput screeningsplit‐ubiquitin yeast two‐hybrid (Y2H) system

Substances

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Antiviral AgentsPlant ExtractsAngiotensin-Converting Enzyme 2ACE2 protein, humanDrugs, Chinese Herbal

Authors and institutions

  • School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, China.
  • College of Pharmacy, Jinan University, Guangzhou, China.
  • Amway (China) R&D Co. Ltd., Guangzhou, China.
  • Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, China.

ORCID profiles: Yujing Huang, Haibo Zhou, Junxia Zheng

Funding

  • Guangzhou Basic and Applied Basic Research Foundation - Science and Technology Elite "Piloting" Project
  • National Natural Science Foundation of China
  • GuangDong Basic and Applied Basic Research Foundation Natural Science Foundation Project
  • GuangDong Basic and Applied Basic Research Foundation Enterprise Joint Foundation

Cite

APA

Huang, Y., Luo, R., Tian, C., Zu, D., Yang, J., Chen, W., Huang, D., Duan, S., Yan, S., Yuan, Y., Li, S., Zhou, H., Lin, F., He, Q., & Zheng, J. (2025). Dual Assay Validation of Rosmarinus officinalis Extract as an Inhibitor of SARS‐CoV‐2 Spike Protein: Combining Pseudovirus Testing, Yeast Two‐Hybrid, and UPLC‐Q Exactive Orbitrap‐MS Profiling. Phytochemical Analysis. https://doi.org/10.1002/pca.3467

Vancouver

Huang Y, Luo R, Tian C, Zu D, Yang J, Chen W, et al. Dual Assay Validation of Rosmarinus officinalis Extract as an Inhibitor of SARS‐CoV‐2 Spike Protein: Combining Pseudovirus Testing, Yeast Two‐Hybrid, and UPLC‐Q Exactive Orbitrap‐MS Profiling. Phytochemical Analysis. 2025. doi:10.1002/pca.3467

BibTeX
@article{Huang2025,
  author = {Huang, Yujing and Luo, Rufeng and Tian, Chenjing and Zu, Duntao and Yang, Jianni and Chen, Wenlin and Huang, Dingqiang and Duan, Siyan and Yan, Shunxin and Yuan, Yujia and Li, Shengrong and Zhou, Haibo and Lin, Fulong and He, Qinghui and Zheng, Junxia},
  title = {Dual Assay Validation of Rosmarinus officinalis Extract as an Inhibitor of SARS‐CoV‐2 Spike Protein: Combining Pseudovirus Testing, Yeast Two‐Hybrid, and UPLC‐Q Exactive Orbitrap‐MS Profiling},
  journal = {Phytochemical Analysis},
  year = {2025},
  doi = {10.1002/pca.3467}
}
Start for free →